Claritas Pharmaceuticals Inc V.CLAS.H

Transformative Innovation To Mental Health

[LitsonButiki]

Sponsored post:

Mental Health, Substance Use, and Chronic Pain problems have not been appropriately addressed. To the tune that there has been approximately $8.5 trillion lost in economic output due to these issues. 1 in 3 Canadians meet the criteria for at least one mental or substance use disorder in their lifetime, and 1 in 4 Canadians aged 15 or older live with chronic pain. Luckily, there are lucrative medical frontiers that have the potential to serve an improperly addressed and underserved market.Manifest your thoughts and stay up to date on the latest mental healthcare news here!

 

Transformative innovation coming to the mental health, addiction, and chronic pain spaces is desperately overdue. Luckily, by blending traditional health systems with the new frontier of value-based health solutions, including psychedelic medicines and digitization, for better patient outcomes, these other industries could possibly be some of the most revolutionary and lean in the sector.

 

Around 80% of patients describe their psychedelic experience as one of the “most personally meaningful and spiritually significant experiences of their life.” The actual root cause of symptoms is being addressed for the first time instead of “band-aids” that may or may not work. The best part? we could finally make these treatments more accessible for the long-suffering Canadian public and soon to the US! Explore the holistic approach of psychedelics through this article for more related insights regarding these potential cures.

Check disclaimer on profile and landing page.